NCT07552909 A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
| NCT ID | NCT07552909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Condition | Attention Deficit Hyperactivity Disorder (ADHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 146 participants |
| Start Date | 2025-08-24 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 146 participants in total. It began in 2025-08-24 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Explore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.
Eligibility Criteria
Inclusion Criteria: * Children aged 7 years 0 months to 11 years 11 months * Clinical diagnosis of ADHD made by a child psychiatrist at the attending level or above * Wechsler Intelligence Scale for Children (WISC) Full Scale IQ (FSIQ) above 85 * Children who have been diagnosed with ADHD but have not received any intervention (newly diagnosed within the last month or not having taken medication for at least 4 weeks) * Informed consent must be obtained from the patient/guardian and from participants Exclusion Criteria: * Auditory or visual illness or disorder * Inability to use software (e.g., color blindness, impaired hand function, or disability) * Comorbid oppositional defiant disorder, autism spectrum disorder, pervasive developmental disorder, tic disorders, or other neurodevelopmental disorders * Other mental illnesses such as organic mental disorders, schizophrenia, bipolar disorder, or depressive disorders * Attention deficit disorder caused by organic neurological diseases or other organic diseases * Previous regular ADHD medication use as prescribed by a doctor, but without efficacy * Past or present gaming addiction * Previous neurofeedback-like "brain control game" interventions * Previous physical therapy such as magnetic stimulation.
Contact & Investigator
Weiping Xia, PhD
STUDY DIRECTOR
Department of Clinical Psychology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School
Frequently Asked Questions
Who can join the NCT07552909 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 11 Years, studying Attention Deficit Hyperactivity Disorder (ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07552909 currently recruiting?
Yes, NCT07552909 is actively recruiting participants. Contact the research team at summertree20@163.com for enrollment information.
Where is the NCT07552909 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07552909 clinical trial?
NCT07552909 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. The principal investigator is Weiping Xia, PhD at Department of Clinical Psychology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School. The trial plans to enroll 146 participants.